NCT07087938Visszavonva1/2. fázis
Cannabichromene Safety in Rheumatoid Arthritis
Safety and Behavioral Pharmacology of Cannabichromene as an Adjunct to Rheumatoid Arthritis Treatment; Effects on Inflammatory Markers and Rheumatoid Arthritis Disease Activity
Forrás: ClinicalTrials.gov · Utoljára frissítve: 2026. szept. 23.
Megadott ok: Study did not begin recruiting participants due to insufficient preclinical evidence resulting in FDA clinical hold.
Rövid összefoglaló (regiszter, angolul)
For this quantitative study, the investigators will collect data on human safety and side-effects of Cannabichromene (CBC) and whether CBC reduces blood inflammatory markers and Rheumatoid Arthritis (RA) disease activity. The participants will participate in an ABAB design with 2 doses of CBC across the A phases. They will attend 5 in-person clinic visits where they will have physical evaluations, complete self-report forms, and have blood drawn for the following tests: hs-CRP, ESR, IL-6, TNF, Complete Blood Count [CBC], and CMP.
- Állapot (regiszter)
- Visszavonva
- Fázis (regiszter)
- 1/2. fázis
- Vizsgálattípus
- Beavatkozással járó
- Résztvevők száma
- 0 (tényleges)
- Első benyújtás
- 2024. máj. 31.
- Kezdés
- 2028. júl. 15.
- Elsődleges befejezés
- 2030. máj. 31.
- Fő szponzor
- Crystal Lederhos Smith
- Betegségek
- Rheumatoid arthritis
- NCT-szám
- NCT07087938
Ki nem vehet részt
Szó szerint a(z) ClinicalTrials.gov forrásból, témák szerint csoportosítva. Hogy ki vehet részt, azt csak a vizsgálat csapata dönti el.
Korábbi kezelés
- Has not received stable treatment for at least 1 month prior to the study or is unwilling to continue treatment for the duration of the study
- Is planning a surgery during the course of their participation in the trial
Más betegség
- No degree of disease activity present at research study intake (determined by research study personnel)
Életkor
- Under age 21
Egyéb
- Do not have a current diagnosis of RA
- Unable to read and speak English, or provide written consent
- Are currently pregnant or planning to become pregnant during the course of the trial
- Unwilling to use a form of birth control during the duration of the study
- Unwilling to refrain from cannabis use (other than study provided CBC) over the course of the study
Kiket keres a vizsgálat
- Have a current diagnosis of RA
- Having stable treatment for at least 1 month prior to the study and being willing to continue that treatment for the duration of the study
- Having some degree of disease activity present at research study intake (determined by research study personnel)
- Aged 21+
- Able to read and speak English, and provide written consent
- Not currently pregnant or planning to become pregnant during the trial
- Not currently planning any surgeries during the course of the trial
- Willing to use a form of birth control for the duration of the study (all participants will be required to use birth control for the duration of the study)
- Willing to refrain from cannabis use (other than study provided CBC) over the course of the study
Életkor a regiszterben: 21 év – - · Nem: nők és férfiak · Egészséges önkénteseket nem fogad
Helyszínek (1)
Helyszínek a regiszter sorrendjében. Ha a profilodba mented a városodat, távolság szerint rendeződnek.
| Helyszín | Város | Ország | Helyszín állapota |
|---|---|---|---|
| Washington State University | Spokane | Egyesült Államok | Ismeretlen állapot |
Ez az oldal tájékoztatás, nem orvosi tanács. Bármely vizsgálatról az orvosoddal beszélj.